|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for GLRA3 |
 Gene summary |
| Basic gene Info. | Gene symbol | GLRA3 |
| Gene name | glycine receptor, alpha 3 | |
| Synonyms | - | |
| Cytomap | UCSC genome browser: 4q34.1 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001042543.2, NM_006529.3, | |
| Description | glycine receptor subunit alpha-3glycine receptor, alpha-3 polypeptideligand gated ion channel | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 600421 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000145451 | ||
| HPRD : 02688 | ||
| Vega : OTTHUMG00000149816 | ||
| Protein | UniProt: O75311 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_GLRA3 | |
| BioGPS: 8001 | ||
| Pathway | NCI Pathway Interaction Database: GLRA3 | |
| KEGG: GLRA3 | ||
| REACTOME: GLRA3 | ||
| Pathway Commons: GLRA3 | ||
| Context | iHOP: GLRA3 | |
| ligand binding site mutation search in PubMed: GLRA3 | ||
| UCL Cancer Institute: GLRA3 | ||
| Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID |
| Top |
| Ligand binding site mutations for GLRA3 |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | R98 | Q99H | BLCA | 1 | R98 | R98C | COAD | 1 | F240 | C242Y | LUAD | 1 | L160 | L160F | SKCM | 1 | R98 | R98C | SKCM | 1 | R98 | R98C | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for GLRA3 |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | L160 | L160F | -1.4543401 | R98 | Q99H | -1.1018772 | R98 | R98C | -0.8710116 | F240 | C242Y | -0.49034464 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for GLRA3 from PDB |
| Top |
| Differential gene expression and gene-gene network for GLRA3 |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for GLRA3 |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for GLRA3 |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Gene-centered drug-gene interaction network |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Approved|nutraceutical|vet_approved | DB00145 | Glycine | Small molecule |  |
| Approved|withdrawn | DB00431 | Lindane | Small molecule |  |
| Experimental | DB00466 | Picrotoxin | Small molecule |  |
| Approved|vet_approved | DB00602 | Ivermectin | Small molecule |  |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of GLRA3 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
| Top |
| Conservation information for LBS of GLRA3 |
| Multiple alignments for O75311 in multiple species |
| LBS | AA sequence | # species | Species | E190 | CIMQLESFGYT | 2 | Homo sapiens, Mus musculus | E190 | CNFDLVSYAHT | 1 | Caenorhabditis elegans | F192 | MQLESFGYTMN | 2 | Homo sapiens, Mus musculus | F192 | FDLVSYAHTMN | 1 | Caenorhabditis elegans | F240 | YNTGKFTCIEV | 2 | Homo sapiens, Mus musculus | F240 | TNTGSYGCLRM | 1 | Caenorhabditis elegans | F77 | VTCNIFINSFG | 2 | Homo sapiens, Mus musculus | F77 | VRVNIMIRMLS | 1 | Caenorhabditis elegans | F96 | YRVNIFLRQKW | 2 | Homo sapiens, Mus musculus | F96 | YSIQLTFREQW | 1 | Caenorhabditis elegans | L150 | TTDNKLLRIFK | 2 | Homo sapiens, Mus musculus | L150 | DMENMFLRIYP | 1 | Caenorhabditis elegans | L160 | KNGNVLYSIRL | 2 | Homo sapiens, Mus musculus | L160 | PDGKILYSSRI | 1 | Caenorhabditis elegans | R152 | DNKLLRIFKNG | 2 | Homo sapiens, Mus musculus | R152 | ENMFLRIYPDG | 1 | Caenorhabditis elegans | R98 | VNIFLRQKWND | 2 | Homo sapiens, Mus musculus | R98 | IQLTFREQWID | 1 | Caenorhabditis elegans | T237 | TKHYNTGKFTC | 2 | Homo sapiens, Mus musculus | T237 | TSHTNTGSYGC | 1 | Caenorhabditis elegans | Y235 | YCTKHYNTGKF | 2 | Homo sapiens, Mus musculus | Y235 | DCTSHTNTGSY | 1 | Caenorhabditis elegans |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |